FORM — Formoplast Balance Sheet
0.000.00%
- €14.74m
- -€16.62m
- €203.43m
Annual balance sheet for Formoplast, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | fx Preliminary |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.123 | 0.144 | 0.189 | 0.389 | 40.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.259 | 0.256 | 0.155 | 26.2 | 69.6 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.595 | 0.626 | 0.471 | 36.8 | 310 |
| Net Property, Plant And Equipment | 4.02 | 4.21 | 4.55 | 4.81 | 0.753 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 4.81 | 5.04 | 5.02 | 43.1 | 324 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.171 | 0.219 | 0.408 | 13.1 | 294 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.2 | 0.225 | 0.886 | 37 | 317 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 4.61 | 4.81 | 4.13 | 6.09 | 7.57 |
| Total Liabilities & Shareholders' Equity | 4.81 | 5.04 | 5.02 | 43.1 | 324 |
| Total Common Shares Outstanding |